CSL (OTCMKTS:CSLLY) Shares Gap Down – Here’s What Happened

CSL Limited Sponsored ADR (OTCMKTS:CSLLY)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $60.97, but opened at $57.22. CSL shares last traded at $59.7090, with a volume of 14,831 shares trading hands.

Wall Street Analyst Weigh In

A number of brokerages have commented on CSLLY. Zacks Research downgraded shares of CSL from a “hold” rating to a “strong sell” rating in a research note on Tuesday, November 18th. Canaccord Genuity Group raised shares of CSL from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 28th. Two analysts have rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, CSL currently has a consensus rating of “Buy”.

CSL Stock Performance

The business’s fifty day simple moving average is $62.74 and its two-hundred day simple moving average is $72.19. The company has a current ratio of 2.46, a quick ratio of 1.12 and a debt-to-equity ratio of 0.50.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.